Amicus Therapeutics (FOLD) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Amicus Therapeutics (FOLD) over the last 15 years, with Q3 2025 value amounting to $1.9 million.
- Amicus Therapeutics' Accumulated Depreciation & Amortization fell 1364.06% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 1364.06%. This contributed to the annual value of $8.5 million for FY2024, which is 856.09% up from last year.
- Amicus Therapeutics' Accumulated Depreciation & Amortization amounted to $1.9 million in Q3 2025, which was down 1364.06% from $1.9 million recorded in Q2 2025.
- Over the past 5 years, Amicus Therapeutics' Accumulated Depreciation & Amortization peaked at $8.5 million during Q4 2024, and registered a low of $1.3 million during Q1 2023.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $1.9 million (2025), whereas its average is $2.9 million.
- In the last 5 years, Amicus Therapeutics' Accumulated Depreciation & Amortization tumbled by 3910.26% in 2021 and then skyrocketed by 7325.04% in 2023.
- Quarter analysis of 5 years shows Amicus Therapeutics' Accumulated Depreciation & Amortization stood at $6.2 million in 2021, then dropped by 13.96% to $5.3 million in 2022, then surged by 47.38% to $7.9 million in 2023, then rose by 8.56% to $8.5 million in 2024, then crashed by 78.07% to $1.9 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $1.9 million for Q3 2025, versus $1.9 million for Q2 2025 and $1.8 million for Q1 2025.